Jiangsu Skyray Instrument Co Ltd
SZSE:300165
Jiangsu Skyray Instrument Co Ltd
Cost of Revenue
Jiangsu Skyray Instrument Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Skyray Instrument Co Ltd
SZSE:300165
|
Cost of Revenue
-¥968.4m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-23%
|
|
A
|
APT Medical Inc
SSE:688617
|
Cost of Revenue
-¥486.1m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cost of Revenue
-¥3.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-15%
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cost of Revenue
-¥12.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cost of Revenue
-¥2.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-20%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cost of Revenue
-¥5.9B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Skyray Instrument Co Ltd's Cost of Revenue?
Cost of Revenue
-968.4m
CNY
Based on the financial report for Sep 30, 2023, Jiangsu Skyray Instrument Co Ltd's Cost of Revenue amounts to -968.4m CNY.
What is Jiangsu Skyray Instrument Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-23%
Over the last year, the Cost of Revenue growth was -86%. The average annual Cost of Revenue growth rates for Jiangsu Skyray Instrument Co Ltd have been -29% over the past three years , -11% over the past five years , and -23% over the past ten years .